Tools commonly used in the Bone Marrow Registry industry for day-to-day tasks and operations.

• Flow cytometers
• DNA sequencers
• Cryogenic storage tanks
• Automated cell sorters
• Microscopes
• Centrifuges
• PCR machines
• Liquid nitrogen tanks
• Hematology analyzers
• Cell culture incubators

Common products and services typical of NAICS Code 621991-06, illustrating the main business activities and contributions to the market.

• Bone marrow donor registry
• Bone marrow transplant center
• Hematology laboratory
• Stem cell research facility
• Blood cancer treatment center
• Bone marrow biopsy clinic
• Cellular therapy center
• Hematopoietic stem cell bank
• Bone marrow collection facility
• Cord blood bank

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• FACT Accreditation: FACT (Foundation for the Accreditation of Cellular Therapy) is an international organization that accredits bone marrow transplant programs. The accreditation process includes an on-site inspection and evaluation of the program's compliance with FACT standards. Accreditation is required for reimbursement by some insurance companies and for participation in some clinical trials.
• CLIA Certification: The Clinical Laboratory Improvement Amendments (CLIA) program regulates laboratory testing and requires clinical laboratories to be certified by the Centers for Medicare & Medicaid Services (CMS) before they can accept human samples for diagnostic testing. Bone marrow registries that perform HLA typing and other laboratory tests must be CLIA certified.
• FDA Registration: Bone marrow registries that collect and process human cells and tissues must register with the FDA and comply with FDA regulations.
• HIPAA Compliance: The Health Insurance Portability and Accountability Act (HIPAA) sets national standards for the protection of individuals' medical records and other personal health information. Bone marrow registries must comply with HIPAA regulations to protect the privacy and security of donors' and patients' health information.
• NMDP Accreditation: The National Marrow Donor Program (NMDP) is a nonprofit organization that operates the Be The Match Registry, which is the largest and most diverse bone marrow registry in the world. The NMDP accredits transplant centers and collection centers that participate in the registry. Accreditation is required for reimbursement by some insurance companies and for participation in some clinical trials.

A concise historical narrative of NAICS Code 621991-06 covering global milestones and recent developments within the United States.

• The Bone Marrow Registry industry has a relatively short history, with the first bone marrow transplant being performed in 1956. The first bone marrow registry was established in 1974 in Copenhagen, Denmark, and was followed by the establishment of the National Marrow Donor Program (NMDP) in the United States in 1986. The NMDP was created to help patients in need of bone marrow transplants find suitable donors. In 1988, the first unrelated bone marrow transplant was performed, and in 1990, the NMDP facilitated its 1,000th transplant. In recent years, advancements in technology have made it easier to match donors with patients, and the industry has seen an increase in the number of transplants performed. In the United States, the Bone Marrow Registry industry has seen significant growth in recent years. In 2012, the NMDP facilitated over 6,000 transplants, and by 2019, that number had increased to over 8,000. The industry has also seen advancements in the use of cord blood as a source of stem cells for transplants. In 2018, the FDA approved the use of a new technology that allows for the expansion of cord blood stem cells, which could increase the number of transplants that can be performed. Overall, the Bone Marrow Registry industry has made significant strides in improving the lives of patients in need of bone marrow transplants.

The anticipated future trajectory of the NAICS 621991-06 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The Bone Marrow Registry industry in the USA is expected to grow in the coming years due to the increasing demand for bone marrow transplants. According to a report by ResearchAndMarkets.com, the global bone marrow transplant market is expected to grow at a CAGR of 5.5% from 2020 to 2027. This growth is attributed to the rising prevalence of blood cancer and other blood disorders, as well as the increasing number of bone marrow transplant procedures being performed. Additionally, advancements in technology and the development of new therapies are expected to drive growth in the industry. However, the industry may face challenges such as high costs associated with bone marrow transplants and a shortage of donors. Overall, the future outlook for the Bone Marrow Registry industry in the USA is positive, with growth expected in the coming years.

Recent groundbreaking advancements and milestones in the Bone Marrow Registry industry, reflecting notable innovations that have reshaped its landscape.

• The National Marrow Donor Program (NMDP) launched a new platform called the "Be The Match BioBank" in 2020, which aims to collect and store biological samples from donors and patients to support research and development of new treatments. This platform is expected to accelerate the development of new therapies and improve patient outcomes.
• In 2019, the NMDP announced a partnership with the US Department of Defense to increase the number of bone marrow donors and improve access to bone marrow transplants for military service members and their families.
• In 2018, the NMDP launched a new program called "Be The Match Connect" which provides patients and their families with access to resources and support throughout the bone marrow transplant process.
• In 2017, the NMDP announced a partnership with the American Society for Blood and Marrow Transplantation (ASBMT) to develop new guidelines for the use of bone marrow transplants in patients with sickle cell disease.
• In 2016, the NMDP launched a new program called "Be The Match Patient Support Center" which provides patients and their families with access to support and resources throughout the bone marrow transplant process.